Mitroflow Aortic Pericardial Heart Valve
FDA PMAClass III (US FDA PMA)
Identity
- Trade Name
- MITROFLOW AORTIC PERICARDIAL HEART VALVE FDA PMA
- Generic Name
- heart-valve, non-allograft tissue FDA PMA
Identifiers
- PMA Number
- P060038 FDA PMA
- FDA Product Code
- LWR FDA PMA
Classification
- Device Class
- Class III FDA PMA
- Advisory Committee
- Cardiovascular FDA PMA
- FDA Decision
- APWD FDA PMA
The Mitroflo Aortic Pericardial Heart Valve is a Heart-Valve, Non-Allograft Tissue device, designed for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves. Constructed from pericardial tissue, it is intended for surgical implantation to restore hemodynamic function in the aortic position.
This device is supplied in sizes 19, 21, 23, 25, and 27 mm and is intended for single-use in a sterile surgical setting. Approved under FDA_PMA (PMA Number: P060038), it falls under Device Class III and is regulated as a cardiovascular implant. No MRI safety information is specified in the available data.
Frequently asked questions
What sizes are available for the Mitroflo Aortic Pericardial Heart Valve, and how does this affect its use in surgery?
The Mitroflo Aortic Pericardial Heart Valve is available in five sizes: 19 mm, 21 mm, 23 mm, 25 mm, and 27 mm. These sizes are designed to accommodate varying patient anatomies, allowing surgeons to select the appropriate valve size to ensure proper hemodynamic function and fit during aortic valve replacement. The sizing range reflects the device’s intent for both pediatric and adult patients with diseased or malfunctioning native or prosthetic aortic valves.
Is the Mitroflo Aortic Pericardial Heart Valve intended for reuse, or is it meant for single-use only?
The Mitroflo Aortic Pericardial Heart Valve is explicitly intended for **single-use** in a sterile surgical setting. This is a standard practice for pericardial tissue-based heart valves to maintain sterility and prevent cross-contamination, ensuring patient safety during implantation.
How is the Mitroflo Aortic Pericardial Heart Valve regulated, and what does this mean for its use in clinical practice?
The Mitroflo Aortic Pericardial Heart Valve is classified as a **Device Class III** and is regulated under the **FDA_PMA (Premarket Approval)** pathway, with PMA Number **P060038**. This classification indicates it is a high-risk device requiring rigorous clinical evaluation before approval. Clinically, this means the valve has undergone thorough testing to demonstrate safety and effectiveness for replacing diseased, damaged, or malfunctioning native or prosthetic aortic valves, providing confidence in its use for aortic valve replacement surgeries.
What should clinicians consider regarding storage and handling of the Mitroflo Aortic Pericardial Heart Valve before surgical use?
Since the Mitroflo Aortic Pericardial Heart Valve is supplied in a **sterile** configuration for single-use, clinicians must ensure it is stored according to manufacturer guidelines to preserve sterility and integrity. Proper storage typically involves maintaining the valve in its sealed packaging, away from extreme temperatures or moisture, until immediately before use in the operating room. Always follow the included instructions for preparation and handling to avoid contamination or damage.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_PMA
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA PMA | United States | FDA_PMA | P060038 | Class III | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Corcym Canada Corp
Sources (1)
- FDA PMA P060038 24 fields · synced Sep 18, 2026